Quick Facts
What is Humanin?
Humanin is a 24-amino acid peptide encoded in the mitochondrial genome, making it one of the first recognized mitochondrial-derived peptides (MDPs). Discovered during research on Alzheimer's disease, it has demonstrated remarkable neuroprotective effects. Humanin levels decline with age, correlating with increased susceptibility to age-related diseases. Research suggests it may protect against various stressors and promote cellular survival.
How Does Humanin Work?
Humanin acts through multiple mechanisms including binding to IGFBP-3, activating STAT3 signaling, and interacting with BAX to prevent apoptosis. It protects cells from oxidative stress, amyloid-beta toxicity, and serum starvation. Humanin also improves insulin sensitivity and may influence systemic metabolism. Its cytoprotective effects appear to be broad-spectrum.
Research-Backed Benefits
Neuroprotection
Strong EvidenceProtects neurons against amyloid-beta toxicity and other insults.
Anti-Apoptotic
Strong EvidencePrevents programmed cell death in various cell types.
Metabolic Benefits
Moderate EvidenceMay improve insulin sensitivity and metabolic function.
Age-Related Decline
Moderate EvidenceLevels decrease with age, suggesting replacement benefit.
Dosage Guidelines
Disclaimer: This content is for educational purposes only. Peptides are research compounds not approved by the FDA for human use. Always consult with a qualified healthcare provider.
Optimal human dosing not established. HNG (S14G variant) is more potent and stable.
Side Effects & Safety
- Limited human safety data
- Theoretical cancer concern (anti-apoptotic)
- Unknown long-term effects
- Research still early
Frequently Asked Questions
References
- Hashimoto Y, et al. "Humanin neuroprotection." Proc Natl Acad Sci, 2001. PMID: 11438707
Get the Complete Humanin Research Protocol
Join 50,000+ researchers with instant access to our comprehensive peptide resource.